Brief: First Wave Biopharma Completes Patient Screening For Phase 2 Span Adrulipase Clinical Trial In Cystic Fibrosis
May 11 (Reuters) - First Wave BioPharma Inc FWBI.O :
* FIRST WAVE BIOPHARMA COMPLETES PATIENT SCREENING FOR PHASE
2
SPAN ADRULIPASE CLINICAL TRIAL IN CYSTIC FIBROSIS
Source text for Eikon: ID:nGNX3Y2GXr
Further company coverage: FWBI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GridAI Technologies
See all newsBrief: Gridai Technologies Corp - Enters $2.54 Million Private Placement Of Shares And Warrants - SEC Filing
Brief: IBN Announces Latest Episode Of The Techmediawire Podcast Featuring Marshall Chapin, CEO Of Grid Ai Corp.
Brief: Entero Therapeutics Terminated Interim CEO And Chairman Richard Joel Paolone Effective Immediately - SEC Filing
Brief: Entero Therapeutics Inc - Now Offering 15.2 Million Shares Of Common Stock
Brief: Entero Therapeutics Inc Subsidiary Immunogenx Enters Settlement Agreement